(BBY) Best Buy $1.55 EPS vs $1.52 estimate; Revenues $12.9B vs $12.75B (e); guides fiscal EPS $3.10-3.25 vs $3.18 estimate; stock up marginally.
(CC) Circuit City trading down almost 4% after posting poor results.
(DCX) DaimlerChrysler said they can turn Chrysler around, but confirmed that they are in talks to sell the unit.
(GE) GE’s NBS is unveiling new international television station plans for its growth model.
(GENZ) Genzyme Files for Expanded Label for Campath(R) as First-Line Treatment For B-CLL Patients
(GMXR) GMX Resources raised guidance.
(ICGN) ICAgen fell 35% after blowing Phase III sickle Cell studies.
(IMCL) ImClone Systems said Erbitux is showing positive results as a “first line” combination treatment for head and neck cancers in combination therapy.
(JPM) JPMorgan is in talks to build a new 50 story tower near Ground Zero in NYC.
(JTX) Jackson Hewitt released a statement that the DOJ efforts against the company was actually only against one franchisee that operates more than 125 units out of more than 6500 units nationwide; the units account for 2% of revenue; says it does not expect to have its financials adversely affected.
(MU) Micron releasing earnings.
(PRW) Pro-Pharma noted that Tampa General Hospital started dosing patients with Davanat/5-FU in Phase II, first line, advanced biliary cancer clinical trials.
Jon C. Ogg
April 4, 2007
Jon Ogg can be reached at [email protected]; he does not own securities in the companies he covers.
Top Gaining Stocks
Top Losing Stocks